[Automatic translation follows] The culture of freedom since 1826. Le Figaro, the culture of freedom since 1826, the leading general daily newspaper and the leading most visited news site in France. With an audience of over 9 million unique visitors (source: Médiamétrie/NetRatings), the site is characterized by the quality and depth of its content, the result of the complementarity between its paper editorial teams (daily and magazines) and its web editorial team; by its Internet 2.0 uses and the importance of video, which has become a central element of the content offering. Lefigaro.fr also bases its development on the synergies …

Sectors: Media

The Paris Region is a major business and techno hub in Europe. Standing at the crossroads of European and worldwide trade, the Paris Region is France's leading economic region. It represents 31% of French GDP. Consisting of 8 départements and 1,280 municipalities, the Paris Region hosts the largest population of french Regions : 12.5 million inhabitants, that is younger than the national average. As Europe’s leading employment area, it boasts a highly qualified workforce : 33% of French executives. The Paris Region hosts 22% of France’s universities, 25% of its engineering schooland 20% of its business schools. Invest in Paris …

Sectors: National and local authorities

Nous soignons et innovons 365 jours par an. AP-HP (Greater Paris University Hospitals) is a European world-renowned university hospital. Its 39 hospitals treat 8 million people every year: in consultation, emergency, during scheduled or home hospitalizations. The AP-HP provides a public health service for everyone, 24 hours a day. This mission is a duty as well as a great source of pride. AP-HP is the leading employer in the Greater Paris area: 100.000 staff members – doctors, researchers, paramedical staff, administrative personnel and workers – work there. Toutes les spécialités médicales de la néonatologie à la gériatrie en passant par …

Sectors: Health

[Automatic translation follows] 🗞Ouest-France, the leading French daily newspaper! Every day, over 600,000 copies in Normandy, Brittany & Pays de la Loire OUEST-FRANCE Company Founder of the Editorial Committee François Régis Hutin Chairman of the Board Louis Échelard - Director of Publication The associative status: Since the extraordinary general meeting of April 9, 1990, S.A. Ouest-France has been part of a non-profit association under the 1901 law, the "Association for the support of the principles of humanist democracy", chaired by Jacques Duquesne. Location: 58 editorial offices in the 14 departments in Brittany, Lower Normandy and Pays de la Loire, as …

Sectors: Media

[Automatic translation follows] France's leading economic and financial news channel. BFM Business TV is France's leading economic and financial news channel. It stands out for its programming focused on the search for expertise. Programs focusing on economic news have established themselves as economic news events. "Good Morning Business" for example, offers guests, the latest innovations, editorials and information on underlying trends on its set. BFM Business TV is also available live on our website as well as on a dedicated application. Tech, Stock Market, Economy, Real Estate, Business, Automobile, and High-Tech

Sectors: Media

[Automatic translation follows] The ARS Nouvelle-Aquitaine manages and coordinates the health system in the region: management of health prevention and promotion policies, health monitoring (health alerts) and environmental health, organization of care (community medicine and hospital), care in medico-social establishments (elderly, disabled or people facing addictions). It is the contact for health professionals, health establishments and medico-social establishments, local authorities, associations and all health stakeholders in the region.

#WeareBiotech Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen …

Sectors: Biotechnology